THE UK Medicines and
Healthcare products Regulatory
Agency has issued a warning of a
patient level recall of Temozolomide
Hospira Capsules.
According to the MHRA the recall
of the anti-cancer medicine is due
to reports of the capsules splitting
and leaking powder.
UK pharmacists are being
advised to contact all their patients
currently taking Temozolomide and
have them return it for quarantine.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jul 10
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.